Navigation Links
McGill plays important role in new global cancer-research network
Date:4/14/2010

This press release is available in French.

A new network was announced today by the International Cancer Genome Consortium (ICGC), and Dr. Bartha Knoppers, Director of the Centre of Genomics and Policy (CGP) located within the McGill University/Genome Quebec Innovation Centre, will occupy a key role.

The network will decode the genomes from 25,000 cancer samples and create a resource of freely available data that will help cancer researchers around the world. Spanning the European Union, Asia, India and North America, the network's researchers will examine more than 10,000 tumors for cancer types affecting a diversity of organs including blood, brain, breast, colon, kidney, liver, lung, pancreas, stomach, oral cavity and ovary.

Once thought of as a single disease, cancer is now understood to be the result of genetic mutations in cells that disrupt normal functions leading to uncontrollable growth. Because mutations are often specific to a particular type or stage of cancer, systematically mapping the changes that occur in each cancer could provide the foundation for research to identify new therapies, diagnostics and preventive strategies. For this project, research at McGill, like that across the country, will focus on pancreatic cancer.

Knoppers is the Chair of the Ethics and Policy Committee of the IGCC and a member of the Data Access Oversight Committee. She explains that in addition to contributing to this essential decoding work, the CGP will be responsible for ensuring compliance with the ICGC's data-access policy, since it houses the Data Access Compliance Office. It will, in other words, vet all requests for access to the data resulting from this crucial collaboration.

"I am pleased we have this excellent opportunity to support and safeguard such key research," said Knoppers.


'/>"/>

Contact: William Raillant-Clark
william.raillant-clark@mcgill.ca
514-398-2189
McGill University
Source:Eurekalert

Page: 1

Related biology news :

1. McGill, Quebec biotech firm partner for new bone-disease treatment
2. Experts gather at McGill University to address food security challenges
3. McGill garners 19 Canada Research Chairs and more than $17 million in funding
4. McGill/JGH researchers successfully reverse multiple sclerosis in animals
5. McGill University receives almost $63 million under CFI program to support five research projects
6. 2 McGill researchers garner prestigious NSERC Steacie Fellowships
7. Peptides-on-demand: McGill researchers radical new green chemistry makes the impossible possible
8. Forget the antioxidants? McGill researchers cast doubt on role of free radicals in aging
9. MUHC and McGill scientists explain genetic disease first discovered in Quebec 24 years ago
10. Key to curing obesity may lie in worms that destroy their own fat: McGill researchers
11. Boost from McGill, Gates Foundation helps Africans control pharma research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2016)... , March 11, 2016 ... new market research report "Image Recognition Market by Technology ... (Marketing and Advertising), by Deployment Type (On-Premises and Cloud), ... To 2022", published by MarketsandMarkets, the global market is ... to USD 29.98 Billion by 2020, at a CAGR ...
(Date:3/9/2016)... March 9, 2016 This BCC Research report ... of the RNA Sequencing (RNA Seq) market for the ... instruments, tools and reagents, data analysis, and services. ... of the RNA-Sequencing market such as RNA-Sequencing tools and ... main factors affecting each segment and forecast their market ...
(Date:3/8/2016)... 8, 2016   Valencell , the leading ... it has secured $11M in Series D financing. ... new venture fund being launched by UAE-based financial ... existing investors TDF Ventures and WSJ Joshua Fund. ... its triple-digit growth and accelerate its pioneering innovation ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... ... April 29, 2016 , ... Summit for Stem Cell has received a $250,000 ... patient-specific stem cell therapy for the treatment of Parkinson’s disease. The Summit research project ... The Scripps Research Institute in San Diego, CA. , The aim of ...
(Date:4/28/2016)... , ... April 28, 2016 , ... ... ongoing support for Connecticut's innovative, growing companies, today announced the launch of ... financial technology (fintech) companies. , “VentureClash looks to attract the best ...
(Date:4/27/2016)... ... 27, 2016 , ... Shimadzu Scientific Instruments (SSI) will be ... Business Conference and Expo. Shimadzu’s high-performance instruments enable laboratories to test cannabis products ... can stop by booth 1021 to learn how Shimadzu’s instruments can help improve ...
(Date:4/27/2016)... ... 27, 2016 , ... The Board of Directors of Biohaven ... Tilton as Chief Commercial Officer.  Mr. Tilton joined Biohaven from Alexion Pharmaceuticals, Inc. ... responsible for the commercialization of multiple orphan drug indications. Mr. Tilton has ...
Breaking Biology Technology: